2021
DOI: 10.1038/s41374-020-00510-4
|View full text |Cite
|
Sign up to set email alerts
|

GTSE1 promotes prostate cancer cell proliferation via the SP1/FOXM1 signaling pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
22
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(22 citation statements)
references
References 30 publications
0
22
0
Order By: Relevance
“…In this study, we screened GTSE1 as a key gene in ESCC by bioinformatic analysis and preliminarily revealed the aberrant expression of GTSE1 in ESCC and various malignancies by GEPIA and UALCAN databases. GTSE1 has been reported to be highly expressed in many tumors such as hepatocellular carcinoma, 24 prostate cancer, 25 gastric cancer, 26 and breast cancer, 27 whose high expression is associated with cancer progression and can be used as a prognostic indicator. It is involved in inhibiting cell apoptosis and participating in chemical drug resistance, such as cisplatin resistance, paclitaxel resistance, and so on 7,26 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In this study, we screened GTSE1 as a key gene in ESCC by bioinformatic analysis and preliminarily revealed the aberrant expression of GTSE1 in ESCC and various malignancies by GEPIA and UALCAN databases. GTSE1 has been reported to be highly expressed in many tumors such as hepatocellular carcinoma, 24 prostate cancer, 25 gastric cancer, 26 and breast cancer, 27 whose high expression is associated with cancer progression and can be used as a prognostic indicator. It is involved in inhibiting cell apoptosis and participating in chemical drug resistance, such as cisplatin resistance, paclitaxel resistance, and so on 7,26 .…”
Section: Discussionmentioning
confidence: 99%
“…Some studies have suggested that the activation of JNK signaling pathway is involved in CIN cells, and the mechanism may be related to excessive ROS production. 23 We performed a series of GTSE1 has been reported to be highly expressed in many tumors such as hepatocellular carcinoma, 24 prostate cancer, 25 gastric cancer, 26 and breast cancer, 27 First, we initially verified the high expression of GTSE1 in ESCC tissues and cell lines, EC109 and KYSE150. Correlations between its protein levels and patients' clinical data were analyzed, leading to the conclusion that high GTSE1 was related to patients' tumor size, grade, and lymph node metastasis.…”
Section: Activation Of Jnk Signaling Pathway In Escc Cells and Apopto...mentioning
confidence: 99%
“…28,29 In cervical cancer, Zhang et al 1 reported that silencing of LDHA significantly attenuated colony formation ability and invasive capacity of SiHa and HeLa cells. In addition, GTSE1 was reported to increase the expression of SP1 in prostate cancer, 30 and knockdown of SP1 could decrease the expression of LDHA in testicular tumor cells, 31 indicating that GTSE1 may modulate LDHA expression through SP1. In the current study, we found that downregulation of GTSE1 decreased LDHA expression.…”
Section: Discussionmentioning
confidence: 99%
“…Through the tumor-suppressive protein p53, GTSE1 has been implicated in the pathogenesis of several malignant tumors. Previous research has proved its negative regulation in malignant tumors ( Lai et al, 2021 ). Moreover, GTSE1 has been linked to the development of chemoresistance in osteosarcoma ( Xie et al, 2021 ) and hepatocellular carcinoma ( Li et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%